286 related articles for article (PubMed ID: 31918006)
21. Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels.
Álvarez-Córdoba M; Reche-López D; Cilleros-Holgado P; Talaverón-Rey M; Villalón-García I; Povea-Cabello S; Suárez-Rivero JM; Suárez-Carrillo A; Munuera-Cabeza M; Piñero-Pérez R; Sánchez-Alcázar JA
Orphanet J Rare Dis; 2022 Aug; 17(1):311. PubMed ID: 35945593
[TBL] [Abstract][Full Text] [Related]
22. Siblings with the adult-onset slowly progressive type of pantothenate kinase-associated neurodegeneration and a novel mutation, Ile346Ser, in PANK2: clinical features and (99m)Tc-ECD brain perfusion SPECT findings.
Doi H; Koyano S; Miyatake S; Matsumoto N; Kameda T; Tomita A; Miyaji Y; Suzuki Y; Sawaishi Y; Kuroiwa Y
J Neurol Sci; 2010 Mar; 290(1-2):172-6. PubMed ID: 20006850
[TBL] [Abstract][Full Text] [Related]
23. Evidence for a Conserved Function of Eukaryotic Pantothenate Kinases in the Regulation of Mitochondrial Homeostasis and Oxidative Stress.
Ceccatelli Berti C; Gihaz S; Figuccia S; Choi JY; Pal AC; Goffrini P; Ben Mamoun C
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613877
[TBL] [Abstract][Full Text] [Related]
24. Metabolic consequences of mitochondrial coenzyme A deficiency in patients with PANK2 mutations.
Leoni V; Strittmatter L; Zorzi G; Zibordi F; Dusi S; Garavaglia B; Venco P; Caccia C; Souza AL; Deik A; Clish CB; Rimoldi M; Ciusani E; Bertini E; Nardocci N; Mootha VK; Tiranti V
Mol Genet Metab; 2012 Mar; 105(3):463-71. PubMed ID: 22221393
[TBL] [Abstract][Full Text] [Related]
25. Deficiency of pantothenate kinase 2 (Pank2) in mice leads to retinal degeneration and azoospermia.
Kuo YM; Duncan JL; Westaway SK; Yang H; Nune G; Xu EY; Hayflick SJ; Gitschier J
Hum Mol Genet; 2005 Jan; 14(1):49-57. PubMed ID: 15525657
[TBL] [Abstract][Full Text] [Related]
26. Novel compound heterozygous PANK2 gene mutations in a Chinese patient with atypical pantothenate kinase-associated neurodegeneration.
Cheng Y; Liu YT; Yang ZH; Yang J; Shi CH; Xu YM
Int J Neurosci; 2018 Dec; 128(12):1109-1113. PubMed ID: 29962256
[TBL] [Abstract][Full Text] [Related]
27. Pantethine rescues a Drosophila model for pantothenate kinase-associated neurodegeneration.
Rana A; Seinen E; Siudeja K; Muntendam R; Srinivasan B; van der Want JJ; Hayflick S; Reijngoud DJ; Kayser O; Sibon OC
Proc Natl Acad Sci U S A; 2010 Apr; 107(15):6988-93. PubMed ID: 20351285
[TBL] [Abstract][Full Text] [Related]
28. Silencing of pantothenate kinase 2 reduces endothelial cell angiogenesis.
Pagani F; Trivedi A; Khatri D; Zizioli D; Garrafa E; Mitola S; Finazzi D
Mol Med Rep; 2018 Nov; 18(5):4739-4746. PubMed ID: 30221726
[TBL] [Abstract][Full Text] [Related]
29. Infantile neuroaxonal dystrophy and pantothenate-kinase-associated neurodegeneration: locus heterogeneity.
Hörtnagel K; Nardocci N; Zorzi G; Garavaglia B; Botz E; Meitinger T; Klopstock T
Neurology; 2004 Sep; 63(5):922-4. PubMed ID: 15365152
[TBL] [Abstract][Full Text] [Related]
30. Atypical pantothenate kinase-associated neurodegeneration with PANK2 mutations : clinical description and a review of the literature.
Pan S; Zhu C
Neurocase; 2020 Jun; 26(3):175-182. PubMed ID: 32310012
[TBL] [Abstract][Full Text] [Related]
31. Plant coenzyme A biosynthesis: characterization of two pantothenate kinases from Arabidopsis.
Tilton GB; Wedemeyer WJ; Browse J; Ohlrogge J
Plant Mol Biol; 2006 Jul; 61(4-5):629-42. PubMed ID: 16897480
[TBL] [Abstract][Full Text] [Related]
32. Pantethine treatment is effective in recovering the disease phenotype induced by ketogenic diet in a pantothenate kinase-associated neurodegeneration mouse model.
Brunetti D; Dusi S; Giordano C; Lamperti C; Morbin M; Fugnanesi V; Marchet S; Fagiolari G; Sibon O; Moggio M; d'Amati G; Tiranti V
Brain; 2014 Jan; 137(Pt 1):57-68. PubMed ID: 24316510
[TBL] [Abstract][Full Text] [Related]
33. Acanthocytosis and the c.680 A>G Mutation in the PANK2 Gene: A Study Enrolling a Cohort of PKAN Patients from the Dominican Republic.
Schiessl-Weyer J; Roa P; Laccone F; Kluge B; Tichy A; De Almeida Ribeiro E; Prohaska R; Stoeter P; Siegl C; Salzer U
PLoS One; 2015; 10(4):e0125861. PubMed ID: 25915509
[TBL] [Abstract][Full Text] [Related]
34. Massive iron accumulation in PKAN-derived neurons and astrocytes: light on the human pathological phenotype.
Santambrogio P; Ripamonti M; Cozzi A; Raimondi M; Cavestro C; Di Meo I; Rubio A; Taverna S; Tiranti V; Levi S
Cell Death Dis; 2022 Feb; 13(2):185. PubMed ID: 35217637
[TBL] [Abstract][Full Text] [Related]
35. Novel homozygous PANK2 mutation causing atypical pantothenate kinase-associated neurodegeneration (PKAN) in a Cypriot family.
Tanteles GA; Spanou-Aristidou E; Antoniou C; Christophidou-Anastasiadou V; Kleopa KA
J Neurol Sci; 2014 May; 340(1-2):233-6. PubMed ID: 24655737
[TBL] [Abstract][Full Text] [Related]
36. Localization and regulation of mouse pantothenate kinase 2.
Leonardi R; Zhang YM; Lykidis A; Rock CO; Jackowski S
FEBS Lett; 2007 Oct; 581(24):4639-44. PubMed ID: 17825826
[TBL] [Abstract][Full Text] [Related]
37. Pantothenate kinase 1 is required to support the metabolic transition from the fed to the fasted state.
Leonardi R; Rehg JE; Rock CO; Jackowski S
PLoS One; 2010 Jun; 5(6):e11107. PubMed ID: 20559429
[TBL] [Abstract][Full Text] [Related]
38. Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: Mechanism of action and efficacy in nonclinical models.
Elbaum D; Beconi MG; Monteagudo E; Di Marco A; Quinton MS; Lyons KA; Vaino A; Harper S
PLoS One; 2018; 13(3):e0192028. PubMed ID: 29522513
[TBL] [Abstract][Full Text] [Related]
39. Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name.
Hayflick SJ
Curr Opin Pediatr; 2003 Dec; 15(6):572-7. PubMed ID: 14631201
[TBL] [Abstract][Full Text] [Related]
40.
Yang F; Wang J; Yang Z; Ren Z; Zeng F
Int J Neurosci; 2022 Jun; 132(6):582-588. PubMed ID: 33043782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
